Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Connecting the Genetic Dots of Disease

Published: Friday, November 09, 2012
Last Updated: Friday, November 09, 2012
Bookmark and Share
Broad Institute scientists aim to understand the underlying biology leading to disease.

When Liz Rossin began the PhD portion of the Harvard/MIT MD-PhD program in the lab of Mark Daly, a ubiquitous and critical problem in genetic research caught her attention. At the time, researchers had identified more than 150 genetic regions scattered throughout the genome tied to various diseases. Such experiments, known as genome-wide association studies (GWAS), would turn up dozens of regions likely harboring genetic changes contributing to risk of disease, but would not point to specific causal mutations. In order to understand the underlying biology leading to disease, Rossin and her colleagues wanted to identify the connections among these regions.

“That’s the problem we were interested in,” says Rossin, who is now finishing medical school at Harvard. “We have all of these regions in the genome associated with disease, but we don’t necessarily know what they mean or what they have to do with one another.”

Inspired by this challenge, Rossin went on to create DAPPLE – Disease Association Protein-Protein Link Evaluator – an algorithm that can help researchers examine possible networks and draw meaningful conclusions from GWAS data by looking at the physical interactions among proteins. DAPPLE has been used to evaluate data for a variety of diseases including Alzheimer’s disease, rheumatoid arthritis, autism, and more.

Most recently, Broad researchers and collaborators used DAPPLE in a study of inflammatory bowel disease, an illness that includes Crohn’s disease (CD) and ulcerative colitis (UC), both inflammatory diseases of the gastrointestinal tract (a paper detailing the results was published in Nature this week – you can check out a Broad press release here or the original paper here). By combining raw data from studies of CD and UC and adding newly collected genetic information, the team was able to more than double the number of genetic regions tied to disease. To draw conclusions from these 160 genetic results, the researchers turned to DAPPLE.

“DAPPLE is a powerful tool for this kind of project,” says Stephan Ripke, one of the first authors of the Nature paper and a researcher at the Broad Institute and Massachusetts General Hospital. “It allows you to build networks and then determine which of those networks make the most sense.”

DAPPLE is a tool of permutation, meaning that it takes proteins in protein-protein interaction databases and rearranges them again and again so that when researchers build a network – say, from 160 regions of the genome tied to IBD – they can compare it to what would be expect by random chance. When Rossin created DAPPLE in Daly’s lab, she teamed up with Kasper Lage, now a researcher at the Broad Institute, and Chris Cotsapas, now an assistant professor at Yale, to populate the algorithm with a list of hundreds of thousands of known protein-protein interactions. Rossin describes these interactions as the “workhorses of the cell” that set off important physical and chemical reactions. DAPPLE uses these known interactions to test possible networks and even predict new associations. In the case of IBD, DAPPLE helped the researchers narrow in on a protein network that implicated genes known to influence how the body responds to pathogens that cause diseases like tuberculosis and leprosy.

“DAPPLE will make an educated guess about all of the genes in a region that could be playing a role in disease, and it will do it for each region, and then ask if the network that it has generated is more connected than would be expected by random chance,” Rossin explains. “If the answer is yes, it will tell you which genes are driving that connection.”

Researchers can then follow up on these critical, driving genes. In previous studies of autism, DAPPLE turned up hits in pathways involved in chromatin remodeling.

“With DAPPLE, you can go from a big list of regions to a narrowed down list of genes that may be very important for your disease,” says Rossin.

Rossin has been impressed by the many uses researchers have found for the algorithm she helped create, several of which she could not have envisioned when DAPPLE was originally built.

“When we created DAPPLE, we wanted to make the tool as accessible as possible, so we built a website that anyone can use – you don’t even have to download it,” she says. “It’s been really exciting for me to see the way people have started using it.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Broad Institute & Google Genomics Combine Bioinformatics and Computing Expertise
Both companies explore how to break down major technical barriers that increasingly hinder biomedical research.
Thursday, June 25, 2015
CRISP-Disp Leverages CRISPR-Cas9 to Deliver RNA Structures to Targets in the Genome
A team of researchers from the Broad Institute and the Harvard Stem Cell Institute has developed CRISP-Disp, a method that expands on the CRISPR-Cas9 system, allowing researchers to display multiple, large RNA structures on the Cas9 protein.
Wednesday, June 10, 2015
GTEx: Useful Expression For Cancer Research
GTEx Project has recently published several papers reporting on findings from its two-year pilot phase.
Tuesday, May 26, 2015
Single-cell Analysis Hits its Stride
Advances in technology and computational analysis enable scale and affordability, paving the way for translational studies.
Saturday, May 23, 2015
Highly Efficient New Cas9 for In Vivo Genome Editing
New finding is expected to expand therapeutic and experimental applications of CRISPR.
Tuesday, April 07, 2015
Broad Institute of MIT and Harvard and Bayer Healthcare Expand their Partnership
Collaboration to develop therapies for cardiovascular disease.
Thursday, April 02, 2015
In vivo CRISPR-Cas9 Screen Sheds Light On Cancer Metastasis And Tumor Evolution
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens.
Friday, March 06, 2015
Scientists Map the Human Loop-ome, Revealing a New Form of Genetic Regulation
Researchers describe the results of a five-year effort to map, in unprecedented detail, how the 2-meter long human genome folds inside the nucleus of a cell.
Tuesday, December 23, 2014
Disorder in Gene-Control System is a Defining Characteristic of Cancer, Study Finds
Findings indicate that the disarray in the on-off mechanism is one of the defining characteristics of cancer.
Tuesday, December 23, 2014
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
Thursday, November 27, 2014
Dramatic Response And Resistance To Cancer Drug Traced
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.
Friday, October 10, 2014
Study Expands the Cancer Genomics Universe
The universe of cancer mutations is much bigger than previously thought, and key cancer genes are still to be discovered.
Tuesday, January 28, 2014
Predicting Cancer’s Next Move
Research offers a new approach to studying drug resistance in cancer.
Monday, November 11, 2013
Mexico-US Genomics Partnership Launches Second Phase
SIGMA 2 is aimed at harnessing genomic medicine for the benefit of Latin America and the world.
Wednesday, October 30, 2013
Understanding Triglycerides’ Role in Coronary Disease
The study leverages new genetic data from a related genome-wide association study, suggests that lowering triglyceride levels through treatment may help reduce the risk of coronary heart disease.
Wednesday, October 09, 2013
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!